Document is current
Any future updates will be listed below
-
Authors
Komatsu, Haruka
Morikubo, Hiromu
Kimura, Yoko
Moue, Chihiro
Yonezawa, Hiromi
Matsuura, Minoru
Miyoshi, Jun
Hisamatsu, Tadakazu https://orcid.org/0000-0002-1178-3536
-
Funding
Funding for this research was provided by:
The Japan Sciences Research Grant for Research on Intractable Diseases
- License Information
-
More Information
Article History
Received: 25 November 2023
Accepted: 7 January 2024
First Online: 21 January 2024
Declarations
:
: Hiromu Morikubo has received grant support from Takeda Pharmaceutical. Minoru Matsuura has received consulting and lecture fees from Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd., AbbVie GK, Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co., Ltd., JIMRO Co., Nippon Kayaku Co. Ltd., Mylan EPD G.K., and Aspen Japan Co. Ltd. Jun Miyoshi has received grant support from AbbVie GK, and consulting and lecture fees from EA Pharma Co. Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Jansen Asia Pacific Pte. Ltd., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, JIMRO Co., Miyarisan Co. Ltd., and Takeda Pharmaceutical Co. Ltd. Tadakazu Hisamatsu has performed Joint Research with Alfresa Pharma Co. Ltd., EA Pharma Co. Ltd. and received grant support from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co. Ltd., AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co. Ltd., Daiichi-Sankyo, Kyorin Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., and Mochida Pharmaceutical Co., Ltd., and consulting and lecture fees from EA Pharma Co. Ltd., AbbVie GK, Celgene K.K., Janssen Pharmaceutical K.K., Pfizer Inc., Nichi-Iko Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Mochida Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co. Ltd. Haruka Komatsu, Yoko Kimura, Chihiro Moue, and Hiromi Yonezawa have no conflict of interest to declare.
: This study was conducted in accordance with the Declaration of Helsinki, and was approved by the Institutional Ethics Committees of Kyorin University School of Medicine (Approval Number 1668). This study used recorded data, and the ethics committee approved a waiver for informed consent.
